Early trial tests targeted drug for deadly brain tumor
Disease control
Not yet recruiting
This study is testing a new drug called BGB-58067 for adults newly diagnosed with a fast-growing brain cancer called glioblastoma (GBM). The main goals are to see if the drug reaches the brain tumor effectively and if it is safe. The study will also check if the drug helps patien…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC